Cargando…
Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts
BACKGROUND: Antiangiogenic agents that disrupt the vascular endothelial growth factor pathway have been demonstrated to normalize tumor vasculature and improve tumor oxygenation in some studies and to induce hypoxia in others. The aim of this preclinical study was to investigate the effect of suniti...
Autores principales: | Gaustad, Jon-Vidar, Simonsen, Trude G, Leinaas, Marit N, Rofstad, Einar K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489843/ https://www.ncbi.nlm.nih.gov/pubmed/22947392 http://dx.doi.org/10.1186/1471-2407-12-388 |
Ejemplares similares
-
High Interstitial Fluid Pressure Is Associated with Tumor-Line Specific Vascular Abnormalities in Human Melanoma Xenografts
por: Simonsen, Trude G., et al.
Publicado: (2012) -
The Effect of Sunitinib Treatment in Human Melanoma Xenografts: Associations with Angiogenic Profiles()
por: Gaustad, Jon-Vidar, et al.
Publicado: (2017) -
Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2013) -
Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2019) -
Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2017)